Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic acid injection versus extracorporeal shockwave therapy for chronic plantar fasciitis
RBR-97vkx4Not yet recruiting
- Sponsor
- Prevent Senior
- Start
- Oct 2020
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial of HyFIVE in plantar fasciitis (2 arms), sponsored by Prevent Senior. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
HyFIVE
03
Conditions
plantar fasciitis
Beyond the preview
Go deeper on RBR-97vkx4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-97vkx4.